Tirzepatide: GLP-1 + GIP dual agonist
Common side effects reported in trials include: Nausea and vomiting (most common during titration) Diarrhea or constipation Decreased appetite (generally desired) Mild injection site reactions Fatigue during early treatment phases Serious side effects are rare but may include pancreatitis or gallbladder issues
Para perder peso y preservar la masa muscular durante el tratamiento con semaglutida, tambin es fundamental realizar actividad fsica de forma regular, incluyendo ejercicios aerbicos y de fuerza
This altered physiology may influence how GLP-1 peptides are absorbed and metabolized in your digestive tract
Bring your most recent lab results, including fasting glucose, HbA1c, lipid panel, thyroid function, and liver enzymes
How to ease into tirzepatide treatment in the first month Think slow and steady. A gentle approach during your tirzepatide starting phase may improve comfort and help you stay consistent: Protect your stomach